MDRX.OTC.PinkVeradigm INC

Form 4: Veradigm Inc. Director Jonathan Judge Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Director Jonathan Judge reports acquisition and disposal of Veradigm Inc. stock, including the award of restricted stock units.

Summary

  • On May 31, 2024, Director Jonathan Judge reported changes in beneficial ownership of Veradigm Inc. stock.
  • Judge acquired 42,106 shares of common stock at a price of $0.
  • These shares were awarded as Restricted Stock Units under the Veradigm, Inc. 2024 Stock Incentive Plan.
  • The grant vests 50% on the grant date (May 31, 2024) and the remaining 50% on the first anniversary of the grant date.
  • Judge also disposed of 174,593 shares.
  • Following these transactions, Judge beneficially owns 174,593 shares of Veradigm Inc. stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of shares through restricted stock units is generally positive, but the disposal of shares tempers the overall sentiment.

Positives

  • The award of Restricted Stock Units to a director signals confidence in the company's future performance.

Negatives

  • The disposal of 174,593 shares by the director could be interpreted negatively by the market.

Risks

  • The vesting schedule of the Restricted Stock Units could influence the director's decisions regarding the company's stock.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the Restricted Stock Units suggests a multi-year commitment from the director.

Industry Context

This filing is a routine disclosure related to insider trading and executive compensation, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Comparison to Industry Standards

  • Stock ownership and trading activity by directors are common and closely monitored in publicly traded companies like Veradigm.
  • Companies like Cerner (now Oracle Health) and Allscripts Healthcare Solutions also have similar reporting requirements for their executives and directors.
  • The vesting schedule of the restricted stock units is a typical incentive mechanism used to align the interests of management with those of shareholders.

Stakeholder Impact

  • Shareholders may be interested in the director's stock transactions as an indicator of confidence in the company.
  • Employees may view the stock incentive plan as a positive aspect of their compensation packages.

Key Dates

DateDescription
05/31/2024Date of transaction and grant of Restricted Stock Units.
05/31/2025First anniversary of the grant date; remaining 50% of Restricted Stock Units vest.
06/20/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.